New data released by GlobalData sheds light on the best mergers and acquisitions in the pharmaceutical industry.

The data show that the activity of mergers and acquisitions is strongest in the United States, where a total of 19 transactions were announced in the last quarter (Q1 of 2022). This is less than the 20 deals announced in the previous quarter (4th quarter of 2021).

India also performed well in the last quarter with 11 deals (from six in the fourth quarter of 2021).

Which countries are emerging as powerful centers for mergers and acquisitions?

As well as being the best deal for mergers and acquisitions in the pharmaceutical industry, India has seen the biggest growth in recent months. The country has announced 15 deals in the last two full quarters, compared to an average of only eight deals every six months between 2019 and 2021.

This is the largest increase in mergers and acquisitions in the pharmaceutical industry in any country.

Although it is the best place to make mergers and acquisitions in the pharmaceutical industry, the United States has had a difficult few months, with only 28 deals announced in the last two full quarters.

This is a decrease compared to the average of 58 deals for the country announced every six months between 2019 and 2021, and the sharpest decline in mergers and acquisitions in the pharmaceutical industry experienced by any country in recent months.

Globally, the situation seems clearly positive for mergers and acquisitions in the pharmaceutical industry.

A total of 125 transactions were announced in the last quarter, compared to 99 transactions in the previous quarter and an average of 76 transactions per quarter in the previous three years.

GlobalData Transaction Database

GlobalData tracks the performance and activities of more than 675,000 companies in over 200 countries worldwide.

The transaction analysis firm’s transaction database includes details of approximately one million transactions, ranging from mergers and acquisitions to venture capital financing, equity proposals and debt offering.

Related companies



https://www.pharmaceutical-technology.com/features/top-and-emerging-locations-for-ma-deals-in-the-pharmaceutical-industry/

Previous articleYouTube’s membership gift feature launches on Wednesday, but in beta
Next articleResearch is underway to develop Marigold UK North Sea using the Piper Bravo platform